Publications

Evolution and dissemination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by DiPersio JR, Deshpande LM, Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1): 1-7

Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: Validation report from the SENTRY Antimicrobial Surveillance Program. by Pottumarthy S, Fritsche TR, Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1):57-62

Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections. by Sader HS, Biedenbach DJ, Streit JM and Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (1): 89-92

Dissemination and diversity of metallo-beta-lactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. by Sader HS, Castanhiera M, Mendes RE, Toleman M, Walsh TR, Jones RN published in Int. J. Antimicrob. Agents 2005; 25 (1): 57-61

Monte Carlo Simulation (MCS) to Estimate In Vitro Susceptibility Breakpoints (BPs) for Moxifloxacin (M), Gatifloxacin (G) and Levofloxacin (L) against Staphylococcus aureus (SA), Lead author: Meagher A, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Use of Pharmacokinetics-Pharmacodynamics and Monte Carlo Simulation as Decision Support for the Re-Evaluation of NCCLS Cephem Susceptibility Breakpoints for Enterobacteriaceae, Lead author: Ambrose PG, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Pharmacokinetic-Pharmacodynamic Target Attainment for Streptococcus pneumoniae for Selected Gatifloxacin Dosing Regimens in Pediatric Patients, Lead author: Bhavnani SM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Association of the bla_VIM-1 Metallo-Beta-Lactamase Gene, the Small Multi-drug Resistance Gene smr, the bla PSE-1 Gene in a Unique Class 1 Integron Found in Pseudomonas aeruginosa Isolates from Sicily: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Walsh T, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Dissemination of bla_VIM-1 Metallo-Beta-Lactamase Genes in Greece via the Transposon Tn21: Report from the SENTRY Surveillance Program, Lead author: Walsh T, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Multi-Resistance Genomic Islands are Found in Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa Isolates from Italian Hospitals: Report from the SENTRY Surveillance Program, Lead author: Toleman MA, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Characterization of Novel Insertion Sequences in bla_IMP-1 Integrons Among Gram-Negative Clinical Isolates in Sao Paulo, Brasil, Lead author: Mendes RE, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Protein Engineering of the Flexible Loops of the IMP and SPM Metallo-Beta-Lactamases Reveals New Insights into Substrate Binding and Hydrolysis, Lead author: Walsh T, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Global Perspective of CR Elements Associated with Metallo-Beta-Lactamase Producing Isolates: Report from the SENTRY Surveillance Program, Lead author: Walsh T, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Emergence of Metallo-Beta-Lactamase among Enterobacteriaceae Causing Bloodstream Infections (BSI): Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Fedler K, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Resistance and Molecular Epidemiology of VRE Isolates from North America and Europe: A Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Decreased Susceptibility Rates against Orally Administered Antimicrobial for Community-Acquired Urinary Tract Infections in Latin America: Report of the SENTRY Antimicrobial Surveillance Program (2003), Lead author: Gales AC, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Variation in Occurrence and Resistance (R) Trends among Community-Acquired Urinary Tract Infections (CA-UTI) Pathogens in North America (NA), Latin America (LA) and Europe (EU): Report from the SENTRY Antimicrobial Surveillance Program (2003), Lead author: Moet G, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Prevalence and Antimicrobial Spectrum of Oral Agents Tested against Gastroenteritis Isolates Recovered in Europe (EU) and Latin America (LA): Report from the SENTRY Antimicrobial Surveillance Program (2003), Lead author: Streit J, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Daptomycin In Vitro Activity Tested against 5,265 Gram-Positive Strains Collected from European and Latin American Medical Centers (2003), Lead author: Streit J, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Trends in Linezolid (LZD) Susceptibility Patterns in 2002 and 2003: Report from the Worldwide ZAAPS Program (16,404 isolates), Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Activity of Gatifloxacin Tested against Isolates from Children < 7 Years of Age: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1998 - 2003), Lead author: Fedler K, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 - November 2, 2004, Washington, DC

Contemporary Causes of Skin and Soft Tissue Infections (SSTI) in Europe: Report from the SENTRY Antimicrobial Surveillance Program (2003), Lead author: Moet G, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Assessment of Pathogens and Resistance Profiles among Bacterial Isolates from Pediatric Patients Hospitalized in Latin American Intensive Care Units (ICUs): Report of the SENTRY Program (2003), Lead author: Gales AC, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Class 1 Integrons as the Origin of Trimethoprim/Sulfamethoxazole (TMP/SMX)-Resistant S. maltophilia Isolates in Europe, Latin America and North America: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Biedenbach DJ, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Activity of Tigecycline Tested against 3,498 Staphylococcus aureus (SA): An Assessment versus Community-Acquired (CA) ORSA, Lead author: Rhomberg PR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Emergence and Epidemic Clonality of Multi-Drug Resistant (MDR) S. pneumoniae (SPN; 1997 – 2003): Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Johnson DM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods: Report from the College of American Pathologists (CAP) Microbiology Surveys Program (2001-2003), Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparison of Broth Microdilution (BMD) and Disk Diffusion (DD) Methods for Susceptibility Testing of Acinetobacter spp. (Acb) Collected Worldwide, Lead author: Swenson J, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Quality Control Guidelines for Broth Microdilution and Disk Diffusion Susceptibility Testing for Polymixin B and Colistin, Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparisons of Inter-Method Susceptibility Testing Accuracy for LBM415 (NVP PDF-713) Using 2,625 Recent Clinical Isolates, Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Campylobacter spp. Susceptibility Testing: A Multi Site Evaluation of Broth Microdilution Methods Compared to the Agar Dilution Method, Lead author: Knapp C, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Re-Evaluation of Enterobacteriaceae Regression/Scattergrams Using ESBL-Enriched Populations Tested against Eight Beta-Lactams, Lead author: Deshpande LM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

International Validation of Alternative Disk Diffusion Methods for Detecting mecA-Mediated Oxacillin (OX) Resistance (R) in Staphylococci: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparative Activity of Dalbavancin Tested against 7,771 Isolates from the USA and Europe (2003), Lead author: Jones RN, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity of Doripenem (DOR) against Multi-Drug Resistant (MDR) Pseudomonas aeruginosa (PSA) and Streptococcus pneumoniae (SPN), Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity of BAL9141 Tested against Staphylococcal Strains with Selected Resistance Patterns, Lead author: Deshpande LM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Activity of Tigecycline (TIG) Tested against Tetracycline-Resistant Enterobacteriaceae, Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Macrolide-Induction, Inoculum Effect and Kill-Curve Analysis of Telithromycin Tested against S. pneumoniae Strains with Characterized MLS_B Resistances, Lead author: Biedenbach DJ, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Comparative Antimicrobial Characterization of LBM415 (NVP PDF-713), a New Peptide Deformylase Inhibitor (PDI), Lead author: Fritsche TR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity of LBM 415 (NVP PDF-713) Tested against Neisseria meningitidis (NM) and N. gonorrhoeae (NG), Lead author: Rhomberg PR, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antimicrobial Activity and Spectrum of PPI-0903 (TAK-599), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains, Lead author: Sader HS, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Evaluation of PPI-0903 (TAK-599), a Novel Cephalosporin: Bactericidal Activity, Effects of Modifying Testing Parameters and Optimization of Disk Diffusion Tests, Lead author: Sader HS, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Evaluating Antimicrobial (ABX) Use & Bacterial Resistance (R): Comparison of the Statistical Power Achieved for Different Regression Methods, Lead author: Bhavnani SM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Evaluation of Patients with ESBL- and Non-ESBL Producing Enterobacteriaceae (ETB): Outcomes Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Bhavnani SM, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

An Outbreak of Catalase-Negative Methicillin-Resistant Staphylococcus aureus, Lead author: Gales AC, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Validation of Etest for Antifungal Susceptibility Testing of 3 Agents using the FDA 510(k) Criteria for Antimicrobial Susceptibility Test (AST) Devices, Lead author: Bolmstrom A, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Antifungal Susceptibility Results from a Worldwide Anidulafungin Surveillance Program (2002-2003), Lead author: Messer S, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003), Lead author: Messer S, presented at 44th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), October 30 – November 2, 2004, Washington, DC

Activity of Tigecycline (TIG) Tested Against Non-Fermentative Gram-negative (NFB) Bacilli other than P. aeruginosa, Lead author: Fritsche TR, presented at 42nd annual Infectious Diseases Society of America (IDSA), September 30 – October 3, 2004, Boston, MA

Antimicrobial Susceptibility of P. aeruginosa and Acinetobacter spp. from Bloodstream Infections (BSI): Comparison of SENTRY Program Results from North America, Latin America and Europe, Lead author: Sader HS, presented at 42nd annual Infectious Diseases Society of America (IDSA), September 30 – October 3, 2004, Boston, MA